Business Description
Chongqing Lummy Pharmaceutical
NAICS : 325411
SIC : 2833
ISIN : CNE100000H10
Share Class Description:
SZSE:300006: Class ACompare
Compare
Traded in other countries / regions
300006.China IPO Date
2009-10-30Description
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.19 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 14.09 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.34 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -24.1 | |||||
3-Year EPS without NRI Growth Rate | 50 | |||||
3-Year FCF Growth Rate | -54.5 | |||||
3-Year Book Growth Rate | 11 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.37 | |||||
9-Day RSI | 52.07 | |||||
14-Day RSI | 48.01 | |||||
6-1 Month Momentum % | -33.06 | |||||
12-1 Month Momentum % | -27.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.59 | |||||
Quick Ratio | 2.33 | |||||
Cash Ratio | 1.35 | |||||
Days Inventory | 244.87 | |||||
Days Sales Outstanding | 142.36 | |||||
Days Payable | 61.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.1 | |||||
Shareholder Yield % | 3.7 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.98 | |||||
Operating Margin % | -4.3 | |||||
Net Margin % | -1.16 | |||||
FCF Margin % | 10.17 | |||||
ROE % | -0.47 | |||||
ROA % | -0.33 | |||||
ROIC % | 0.61 | |||||
ROC (Joel Greenblatt) % | 5.41 | |||||
ROCE % | 0.9 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.01 | |||||
PB Ratio | 1.24 | |||||
Price-to-Tangible-Book | 1.41 | |||||
Price-to-Free-Cash-Flow | 29.76 | |||||
Price-to-Operating-Cash-Flow | 17.06 | |||||
EV-to-EBIT | 94.16 | |||||
EV-to-EBITDA | 94.16 | |||||
EV-to-Revenue | 2.28 | |||||
EV-to-FCF | 22.43 | |||||
Price-to-Projected-FCF | 1.01 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Price-to-Net-Current-Asset-Value | 2.94 | |||||
Price-to-Net-Cash | 81.34 | |||||
Earnings Yield (Greenblatt) % | 1.06 | |||||
FCF Yield % | 3.36 | |||||
Forward Rate of Return (Yacktman) % | 15.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chongqing Lummy Pharmaceutical Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 850.058 | ||
EPS (TTM) (Â¥) | -0.009 | ||
Beta | 0.79 | ||
Volatility % | 34.78 | ||
14-Day RSI | 48.01 | ||
14-Day ATR (Â¥) | 0.112823 | ||
20-Day SMA (Â¥) | 2.4055 | ||
12-1 Month Momentum % | -27.57 | ||
52-Week Range (Â¥) | 2.03 - 4.75 | ||
Shares Outstanding (Mil) | 1,055.91 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Chongqing Lummy Pharmaceutical Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Chongqing Lummy Pharmaceutical Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Chongqing Lummy Pharmaceutical Frequently Asked Questions
What is Chongqing Lummy Pharmaceutical(SZSE:300006)'s stock price today?
The current price of SZSE:300006 is ¥2.44. The 52 week high of SZSE:300006 is ¥4.75 and 52 week low is ¥2.03.
When is next earnings date of Chongqing Lummy Pharmaceutical(SZSE:300006)?
The next earnings date of Chongqing Lummy Pharmaceutical(SZSE:300006) is .
Does Chongqing Lummy Pharmaceutical(SZSE:300006) pay dividends? If so, how much?
Chongqing Lummy Pharmaceutical(SZSE:300006) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |